Effects of ferrous sulphate and non‐ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: Background : Iron deficiency is a common complication of inflammatory bowel disease. Oral iron therapy may reinforce intestinal tissue injury by catalyzing production of reactive oxygen species. Aim : To compare the effects of ferrous sulphate and non‐ionic iron–polymaltose complex on markers of oxidative tissue damage and clinical disease activity in patients with inflammatory bowel disease. Methods : Forty‐one patients with inflammatory bowel disease and iron deficiency were randomized to treatment with ferrous sulphate 100 mg twice a day or iron–polymaltose complex 200 mg once a day for 14 days. Results : Following ferrous sulphate, plasma malondialdehyde increased (P = 0.02), while urine 8‐isoprostaglandin F 2 α and plasma antioxidants did not change significantly. Iron–polymaltose complex did not change plasma malondialdehyde, urine 8‐isoprostaglandin F 2 α or plasma antioxidants. Comparing the two treatments, changes in plasma malondialdehyde tended to differ (P = 0.08), while urine 8‐isoprostaglandin F 2 α and plasma antioxidants did not differ. Neither ferrous sulphate nor iron–polymaltose complex altered clinical disease activity indices. Conclusions : Ferrous sulphate increased plasma malondialdehyde, a marker of lipid peroxidation. Comparing treatment with ferrous sulphate and iron–polymaltose complex, changes in plasma malondialdehyde tended to differ. Clinical disease activity was unchanged after both treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Management of Iron-Deficiency Anaemia
COOK, J. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.022 · Cited by 452 · cited 2×
“P-malondialdehyde (nmol/L) 294 (25) 395 ( 25 )* 275 (21) 300 (19) P-vitamin A (lmol/L) 1.7 (0.2) 1.8 (0.2) 1.6 (0.1) 1.9 (0.3) P-vitamin C (lmol/L) 60.9 (6.0) 58.6 (5.4) 61.3 (5.1) 54.5 (5.5) P-vitamin E (lmol/L) 30.2 (1.8) 29.3 (1.5) 29.3 (1.6) 28.3 (1.7) P-beta-carotene (lmol/L) 0.67 (0.09) 0.67 (0.10) 0.59 (0.13) 0…”
InfluentialCarrier, J., Aghdassi, E., Platt, I., Cullen, J., & Allard, J. P. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01113.x · Cited by 169
Ferrous Fumarate Deteriorated Plasma Antioxidant Status in Patients with Crohn Disease
Erichsen, K., Hausken, T., Ulvik, R. J., Svardal, A., Berstad, A., & Berge, R. K. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000771 · Cited by 91
Self-citation
Cited by
Koskenkorva-Frank, T. S., Weiss, G., Koppenol, W. H., & Burckhardt, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.001 · Cited by 406
Systematic review: managing anaemia in Crohn's disease
KULNIGG, S., & GASCHE, C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03146.x · Cited by 325
Common Misconceptions in the Diagnosis and Management of Anemia in Inflammatory Bowel Disease
Gisbert, J. P., & Gomollón, F. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01846.x · Cited by 230
Anemia and inflammatory bowel diseases
Gomollón, F., & Gisbert, J. P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4659 · Cited by 194
Higher iron bioavailability of a human-like collagen iron complex
Zhu, C., Yang, F., Fan, D., Wang, Y., & Yu, Y. (2017) · Journal of Biomaterials Applications · doi:10.1177/0885328217708638 · Cited by 11
Metadata
- Authors
- ERICHSEN, K., ULVIK, R. J., GRIMSTAD, T., BERSTAD, A., BERGE, R. K., & HAUSKEN, T.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2005-10-14
- Volume
- 22
- Issue
- 9
- Pages
- 831-838
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2019440184
- Cited by
- 70
- References
- 3
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of ferrous sulphate and non‐ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2005.02652.x
- The paper
- ERICHSEN, K., ULVIK, R. J., GRIMSTAD, T., BERSTAD, A., BERGE, R. K., & HAUSKEN, T. (2005). Effects of ferrous sulphate and non‐ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2005.02652.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.